MD-1103

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameMD-1103
Drug Alias NameMD1103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsChild Development Disorders, Pervasive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedday Pharmaceuticals Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedday Pharmaceuticals Sa
Active IndicationsN/A
Inactive IndicationsChild Development Disorders, Pervasive

Other Information

ATC CodeN/A
Related LinksN/A